Insider Stock Trading History of Pollard-knight Denise


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Pollard-knight Denise since year 2005. The trader's CIK number is 1297000. At the time of this reporting, Pollard-knight Denise is the of Oncomed Pharmaceuticals Inc . (stock ticker symbol OMED). See this page for all insider trading activities at Oncomed Pharmaceuticals Inc .

Note that in the past Pollard-Knight Denise also reported insider trading activities as an insider of the following companies:
Stock purchases, sales, and option exercises reported by insider Pollard-knight Denise since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2014-12-31 OMED Oncomed Pharmaceuticals Inc Sale 3,799 21.66 82,301
2014-12-26 OMED Oncomed Pharmaceuticals Inc Sale 2,195 21.65 47,517
2014-12-29 OMED Oncomed Pharmaceuticals Inc Sale 9,902 21.62 214,051
2014-12-30 OMED Oncomed Pharmaceuticals Inc Sale 5,510 21.65 119,285
2014-12-19 OMED Oncomed Pharmaceuticals Inc Sale 20,654 21.71 448,315
2014-12-08 OMED Oncomed Pharmaceuticals Inc Sale 1,727 21.68 37,434
2014-12-09 OMED Oncomed Pharmaceuticals Inc Sale 23,273 21.78 506,979
2014-12-10 OMED Oncomed Pharmaceuticals Inc Sale 7,940 21.77 172,885
2014-12-05 OMED Oncomed Pharmaceuticals Inc Sale 25,000 21.84 546,025
2014-06-30 OMED Oncomed Pharmaceuticals Inc Sale 11,485 23.59 270,919
2014-06-25 OMED Oncomed Pharmaceuticals Inc Sale 3,252 23.56 76,623
2014-06-23 OMED Oncomed Pharmaceuticals Inc Sale 52,797 24.20 1,277,423
2014-06-24 OMED Oncomed Pharmaceuticals Inc Sale 11,764 23.57 277,324
2013-07-23 OMED Oncomed Pharmaceuticals Inc Buy 58,824 17.00 1,000,008
2005-11-14 IDIX Idenix Pharmaceuticals Inc Sale 629,498 20.61 12,973,953

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Pollard-knight Denise ( of Oncomed Pharmaceuticals Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.